CMS has published in the federal register:

• Final Rules for the Medicaid Program:
  1. Delay of Effective Date for Provision Relating to Manufacturer Reporting of Multiple Best Prices Connected to a Value Based Purchasing Arrangement;
  2. Delay of Inclusion of Territories in Definition of States and United States
• Final Rules for the Medicare Program:
  1. CY 2022 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies;
  2. Medicare Shared Savings Program Requirements;
  3. Provider Enrollment Regulation Updates; and
  4. Provider and Supplier Prepayment and Post-Payment Medical Review Requirements
• Final Rules for the Medicare Program Opioid Treatment Programs: CY 2022 Methadone Payment Exception
• A Notice of Agency Information Collection Activities: The HIPAA Eligibility Transaction System (HETS)
• A Notice of Agency Information Collection Activities:
  1. Section 1115 Demonstration Projects Regulations at 42 CFR 431.408, 431.412, 431.420, 431.424, and 431.428
  2. Coverage of Certain Preventive Services Under the Affordable Care Act

CMS has published in the federal register:

• Final Rules for the Medicare and Medicaid Programs:
  1. CY 2022 Home Health Prospective Payment System Rate Update;
  2. Home Health Value-Based Purchasing Model Requirements and Model Expansion;
  3. Home Health and Other Quality Reporting Program Requirements;
  4. Home Infusion Therapy Services Requirements;
  5. Survey and Enforcement Requirements for Hospice Programs;
  6. Medicare Provider Enrollment Requirements; and
  7. COVID-19 Reporting Requirements for Long-Term Care Facilities
• A Notice of Agency Information Collection Activities:
• A Notice of Agency Information Collection Activities:

CMS has published in the federal register:

• Final Rules for the Medicare Program:
  1. End-Stage Renal Disease Prospective Payment System,
  2. Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury,
  3. End-Stage Renal Disease Quality Incentive Program, and
  4. End-Stage Renal Disease Treatment Choices Model
• A Notice of Agency Information Collection Activities: